CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop new vaccines to combat antimicrobial resistance by understanding how the immune system recognizes harmful bacteria versus beneficial ones. It investigates the immune response to specific pathogens and its implications for gut health and vaccine effectiveness.
Antimicrobial resistance (AMR) is a looming global threat, rendering antibiotic treatments useless, and making bacterial infections difficult to treat.
With diminishing antibiotic options to control infectious outbreaks, we must develop new strategies to prevent widespread mortality.
Our group develops novel vaccines to leverage the body’s natural immune responses to fight bacterial infections.
To do this, it is crucial to understand how our immune systems recognize harmful bacteria (“pathogens”…
THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
